235 related articles for article (PubMed ID: 26710181)
1. RISK FACTORS FOR CENTRAL SEROUS CHORIORETINOPATHY: A Systematic Review and Meta-Analysis.
Liu B; Deng T; Zhang J
Retina; 2016 Jan; 36(1):9-19. PubMed ID: 26710181
[TBL] [Abstract][Full Text] [Related]
2. Systemic findings associated with central serous chorioretinopathy.
Tittl MK; Spaide RF; Wong D; Pilotto E; Yannuzzi LA; Fisher YL; Freund B; Guyer DR; Slakter JS; Sorenson JA
Am J Ophthalmol; 1999 Jul; 128(1):63-8. PubMed ID: 10482095
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficiency of Helicobacter pylori eradication in the treatment of patients with acute central serous chorioretinopathy.
Zavoloka O; Bezditko P; Lahorzhevska I; Zubkova D; Ilyina Y
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1737-42. PubMed ID: 26979068
[TBL] [Abstract][Full Text] [Related]
4. Risk factors of chronic obstructive pulmonary disease among adults in Chinese mainland: A systematic review and meta-analysis.
Yang Y; Mao J; Ye Z; Li J; Zhao H; Liu Y
Respir Med; 2017 Oct; 131():158-165. PubMed ID: 28947023
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis.
Ji S; Wei Y; Chen J; Tang S
Int J Clin Pharm; 2017 Jun; 39(3):514-521. PubMed ID: 28386700
[TBL] [Abstract][Full Text] [Related]
6. Systemic factors associated with central serous chorioretinopathy in Koreans.
Eom Y; Oh J; Kim SW; Huh K
Korean J Ophthalmol; 2012 Aug; 26(4):260-4. PubMed ID: 22870024
[TBL] [Abstract][Full Text] [Related]
7. Association between central serous chorioretinopathy and
Wu DW; Jiang FP; Ge G; Zhang MX
Int J Ophthalmol; 2024; 17(6):1120-1127. PubMed ID: 38895673
[TBL] [Abstract][Full Text] [Related]
8. Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis.
Giusti C
Med Hypotheses; 2004; 63(3):524-7. PubMed ID: 15288381
[TBL] [Abstract][Full Text] [Related]
9. Association of Corticosteroid Use With Incidence of Central Serous Chorioretinopathy in South Korea.
Rim TH; Kim HS; Kwak J; Lee JS; Kim DW; Kim SS
JAMA Ophthalmol; 2018 Oct; 136(10):1164-1169. PubMed ID: 30098167
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for central serous chorioretinopathy in pregnant Japanese women.
Morikawa M; Cho K; Kojima T; Chiba K; Ishikawa S; Umazume T; Nakagawa K; Yamada T; Yamada T; Minakami H
J Obstet Gynaecol Res; 2017 May; 43(5):866-872. PubMed ID: 28188952
[TBL] [Abstract][Full Text] [Related]
11. PRESENTATION OF CENTRAL SEROUS CHORIORETINOPATHY IN TWO HUSBAND AND WIFE COUPLES.
Kanesa-Thasan A; Fawzi AA; Gill MK
Retin Cases Brief Rep; 2018 Spring; 12(2):100-102. PubMed ID: 29554052
[TBL] [Abstract][Full Text] [Related]
12. Central serous chorioretinopathy secondary to corticosteroids in patients with atopic disease.
Ricketti PA; Unkle DW; Cleri DJ; Prenner JL; Coluccielo M; Ricketti AJ
Allergy Asthma Proc; 2015; 36(2):123-9. PubMed ID: 25715240
[TBL] [Abstract][Full Text] [Related]
13. [Central serous chorioretinopathy as an extradigestive manifestation of Helicobacter pylori gastric infection].
Asensio-Sánchez VM; Rodríguez-Delgado B; García-Herrero E; Cabo-Vaquera V; García-Loygorri C
Arch Soc Esp Oftalmol; 2008 Mar; 83(3):177-82. PubMed ID: 18311677
[TBL] [Abstract][Full Text] [Related]
14. Central serous chorioretinopathy after renal transplantation.
Lee CS; Kang EC; Lee KS; Byeon SH; Koh HJ; Lee SC
Retina; 2011 Oct; 31(9):1896-903. PubMed ID: 21499191
[TBL] [Abstract][Full Text] [Related]
15. Association between endogenous cortisol level and the risk of central serous chorioretinopathy: a Meta-analysis.
Liang ZQ; Huang LZ; Qu JF; Zhao MW
Int J Ophthalmol; 2018; 11(2):296-300. PubMed ID: 29487822
[TBL] [Abstract][Full Text] [Related]
16. [Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy. Results of the first prospective pilot study].
Mauget-Faÿsse M; Kodjikian L; Quaranta M; Ben Ezra D; Trepsat C; Mion F; Mégraud F
J Fr Ophtalmol; 2002 Dec; 25(10):1021-5. PubMed ID: 12527825
[TBL] [Abstract][Full Text] [Related]
17. Macular pigment optical density in central serous chorioretinopathy.
Sasamoto Y; Gomi F; Sawa M; Tsujikawa M; Hamasaki T
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5219-25. PubMed ID: 20445108
[TBL] [Abstract][Full Text] [Related]
18. Central serous chorioretinopathy in primary hyperaldosteronism.
van Dijk EH; Nijhoff MF; de Jong EK; Meijer OC; de Vries AP; Boon CJ
Graefes Arch Clin Exp Ophthalmol; 2016 Oct; 254(10):2033-2042. PubMed ID: 27393297
[TBL] [Abstract][Full Text] [Related]
19. Central serous chorioretinopathy and glucocorticoids: an update on evidence for association.
Nicholson BP; Atchison E; Idris AA; Bakri SJ
Surv Ophthalmol; 2018; 63(1):1-8. PubMed ID: 28673727
[TBL] [Abstract][Full Text] [Related]
20. Subfoveal Choroidal Thickness in Central Serous Chorioretinopathy: A Meta-Analysis.
Chen G; Tzekov R; Li W; Jiang F; Mao S; Tong Y
PLoS One; 2017; 12(1):e0169152. PubMed ID: 28076442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]